CALCIUM-ANTAGONISTS AND MORTALITY - ANOTHER CASE OF THE NEED FOR CLINICAL JUDGMENT

被引:7
作者
FAGAN, TC
机构
关键词
D O I
10.1001/archinte.155.20.2145
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:2145 / 2145
页数:1
相关论文
共 15 条
[1]   CALCIUM-CHANNEL BLOCKERS AND MYOCARDIAL-INFARCTION - A HYPOTHESIS FORMULATED BUT NOT YET TESTED [J].
BURING, JE ;
GLYNN, RJ ;
HENNEKENS, CH .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 274 (08) :654-655
[2]  
Dahlof B, 1993, Blood Press, V2, P136, DOI 10.3109/08037059309077541
[3]  
DAVIS BR, IN PRESS AM J HYPERT
[5]   SHOULD DIHYDROPYRIDINES BE USED AS FIRST-LINE DRUGS IN THE TREATMENT OF HYPERTENSION - THE CON SIDE [J].
FURBERG, CD ;
PSATY, BM .
ARCHIVES OF INTERNAL MEDICINE, 1995, 155 (20) :2157-2161
[6]   NIFEDIPINE - DOSE-RELATED INCREASE IN MORTALITY IN PATIENTS WITH CORONARY HEART-DISEASE [J].
FURBERG, CD ;
PSATY, BM ;
MEYER, JV .
CIRCULATION, 1995, 92 (05) :1326-1331
[7]  
Hansson L, 1994, Blood Press, V3, P322, DOI 10.3109/08037059409102281
[8]   NIFEDIPINE IN ISCHEMIC-HEART-DISEASE [J].
KLONER, RA .
CIRCULATION, 1995, 92 (05) :1074-1078
[9]   THE CALCIUM-CHANNEL BLOCKER SCARE - LESSONS FOR THE FUTURE [J].
LENFANT, C .
CIRCULATION, 1995, 91 (12) :2855-2856
[10]  
OMAE T, IN PRESS HYPERTENS R